IP Library › Granted Patent US 11,503,848
Granted Patent B2
US 11,503,848 · App. 16/633,745 · Granted Nov 22, 2022

Sweetening and taste-masking compositions, products and uses thereof

Inventors: Tom Nelly A. D'Hoore (Sant Cugat del Vallès, ES); Francisco Borrego Ríos (Sant Cugat del Vallès, ES); Francisco Javier Crespo Montero (Sant Cugat del Vallès, ES)
Assignee: HEALTHTECH BIO ACTIVES, S.L.U
A23L27/33A23L27/84A23L27/86A23L33/28A61K47/40A23L33/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,503,848
App. No.
16/633,745
Granted
Nov 22, 2022
Kind
B2
Abstract

The present invention relates to a sweetening composition comprising neohesperidin dihydrochalcone (NHDC) and gamma-cyclodextrin, to the use of the sweetening composition for sweetening ingestible products, namely, food products and pharmaceuticals, and to an ingestible product comprising the sweetening composition. Furthermore, the present invention also relates to the use of a composition comprising neohesperidin dihydrochalcone and a cyclodextrin selected from beta-cyclodextrin and gamma-cyclodextrin as taste-masking agent, to a process for masking unpleasant tastes in ingestible products, namely in food products and pharmaceuticals, and to ingestible products which comprise unpleasantly tasting substances and the taste-masking composition.

Claims (12)

1. Sweetening composition comprising neohesperidin dihydrochalcone and gamma-cyclodextrin,

wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is comprised between 1.5:1 and 1:10.

2. Composition according to claim 1 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is comprised between 1.5:1 and 1:6.

3. Composition according to claim 1 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is about 1:1.

4. Composition according to claim 1 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is 1±0.1: 1±0.1.

5. Composition according to claim 4 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is 1±0.05: 1±0.05.

6. Composition according to claim 1 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is about 1:3.

7. Composition according to claim 1 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is 1±0.1: 3±0.3.

8. Composition according to claim 7 , wherein the molar ratio of neohesperidin dihydrochalcone:gamma-cyclodextrin is 1±0.05: 3±0.15.

9. Process for sweetening an ingestible product comprising adding the sweetening composition of claim 1 to the ingestible product.

10. The process according to claim 9 , wherein the ingestible product is selected from a food product and a pharmaceutical product.

11. Ingestible product comprising the sweetening composition according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: D'HOORE, TOM NELLY A.; BORREGO RÍOS, FRANCISCO; CRESPO MONTERO, FRANCISCO JAVIER
To: HEALTHTECH BIO ACTIVES, S.L.U.
Reel/Frame 052608/0932 →
Priority Claims (1)
EP 17382503 · Jul 27, 2017 · regional
Continuity (1)
Related Publication 20200170288A1 · Jun 4, 2020
Cited By (1)
US 12,589,135